Modern Healthcare reports HSS joined a national program with internal medicine specialist, Chad M. Craig, MD, MBA, FACP, as the primary site investigator, to test convalescent plasma donated by people who have recovered from COVID-19, as a potential treatment option. In smaller case studies, convalescent plasma is one of the more promising therapies currently available.

Read the full article at Modernhealthcare.com. Please note, a subscription to this publication is required to access.